AR and neoplasm: In hepatocellular carcinoma (HCC), Shi et al. (2017) demonstrated that androgen receptor (AR) transcriptionally activates ADARp110 isoform, which then downregulates circARSP91 (hsa_circ_0085154), a tumor suppressive circRNA.